rs217428

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001101648.2(NPC1L1):​c.3634-9A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.248 in 1,611,844 control chromosomes in the GnomAD database, including 52,495 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.25 ( 5120 hom., cov: 31)
Exomes 𝑓: 0.25 ( 47375 hom. )

Consequence

NPC1L1
NM_001101648.2 intron

Scores

2
Splicing: ADA: 0.00001679
2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.04

Publications

11 publications found
Variant links:
Genes affected
NPC1L1 (HGNC:7898): (NPC1 like intracellular cholesterol transporter 1) The protein encoded by this gene is a multi-pass membrane protein. It contains a conserved N-terminal Niemann-Pick C1 (NPC1) domain and a putative sterol-sensing domain (SSD) which includes a YQRL motif functioning as a plasma membrane to trans-Golgi network transport signal in other proteins. This protein takes up free cholesterol into cells through vesicular endocytosis and plays a critical role in the absorption of intestinal cholesterol. It also has the ability to transport alpha-tocopherol (vitamin E). The drug ezetimibe targets this protein and inhibits the absorption of intestinal cholesterol and alpha-tocopherol. In addition, this protein may play a critical role in regulating lipid metabolism. Polymorphic variations in this gene are associated with plasma total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and coronary heart disease (CHD) risk. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 7-44515974-T-G is Benign according to our data. Variant chr7-44515974-T-G is described in ClinVar as Benign. ClinVar VariationId is 403257.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.29 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPC1L1NM_001101648.2 linkc.3634-9A>C intron_variant Intron 17 of 18 ENST00000381160.8 NP_001095118.1 Q9UHC9A0A0C4DFX6
NPC1L1NM_013389.3 linkc.3715-9A>C intron_variant Intron 18 of 19 NP_037521.2 Q9UHC9-1
NPC1L1XM_011515326.4 linkc.3439-9A>C intron_variant Intron 16 of 17 XP_011513628.1
NPC1L1XM_011515328.3 linkc.1993-9A>C intron_variant Intron 14 of 15 XP_011513630.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPC1L1ENST00000381160.8 linkc.3634-9A>C intron_variant Intron 17 of 18 1 NM_001101648.2 ENSP00000370552.3 A0A0C4DFX6
NPC1L1ENST00000289547.8 linkc.3715-9A>C intron_variant Intron 18 of 19 1 ENSP00000289547.4 Q9UHC9-1
NPC1L1ENST00000546276.5 linkc.3496-9A>C intron_variant Intron 16 of 17 1 ENSP00000438033.1 A0A0C4DGG6

Frequencies

GnomAD3 genomes
AF:
0.250
AC:
37798
AN:
151122
Hom.:
5105
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.294
Gnomad AMI
AF:
0.162
Gnomad AMR
AF:
0.153
Gnomad ASJ
AF:
0.266
Gnomad EAS
AF:
0.00584
Gnomad SAS
AF:
0.151
Gnomad FIN
AF:
0.298
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.266
Gnomad OTH
AF:
0.214
GnomAD2 exomes
AF:
0.211
AC:
52338
AN:
247858
AF XY:
0.212
show subpopulations
Gnomad AFR exome
AF:
0.292
Gnomad AMR exome
AF:
0.110
Gnomad ASJ exome
AF:
0.253
Gnomad EAS exome
AF:
0.00256
Gnomad FIN exome
AF:
0.289
Gnomad NFE exome
AF:
0.260
Gnomad OTH exome
AF:
0.224
GnomAD4 exome
AF:
0.248
AC:
361547
AN:
1460606
Hom.:
47375
Cov.:
38
AF XY:
0.245
AC XY:
177826
AN XY:
726524
show subpopulations
African (AFR)
AF:
0.301
AC:
10071
AN:
33456
American (AMR)
AF:
0.117
AC:
5201
AN:
44584
Ashkenazi Jewish (ASJ)
AF:
0.257
AC:
6711
AN:
26116
East Asian (EAS)
AF:
0.00446
AC:
177
AN:
39688
South Asian (SAS)
AF:
0.167
AC:
14348
AN:
86168
European-Finnish (FIN)
AF:
0.287
AC:
15308
AN:
53288
Middle Eastern (MID)
AF:
0.196
AC:
1129
AN:
5768
European-Non Finnish (NFE)
AF:
0.265
AC:
294036
AN:
1111194
Other (OTH)
AF:
0.241
AC:
14566
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
15510
31020
46530
62040
77550
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9768
19536
29304
39072
48840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.250
AC:
37850
AN:
151238
Hom.:
5120
Cov.:
31
AF XY:
0.247
AC XY:
18209
AN XY:
73856
show subpopulations
African (AFR)
AF:
0.294
AC:
12113
AN:
41162
American (AMR)
AF:
0.153
AC:
2321
AN:
15198
Ashkenazi Jewish (ASJ)
AF:
0.266
AC:
923
AN:
3468
East Asian (EAS)
AF:
0.00585
AC:
30
AN:
5124
South Asian (SAS)
AF:
0.150
AC:
712
AN:
4736
European-Finnish (FIN)
AF:
0.298
AC:
3121
AN:
10482
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.266
AC:
17998
AN:
67774
Other (OTH)
AF:
0.211
AC:
441
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
1470
2940
4411
5881
7351
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.263
Hom.:
2369
Bravo
AF:
0.239

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
2.2
DANN
Benign
0.40
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000017
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs217428; hg19: chr7-44555573; COSMIC: COSV56922725; COSMIC: COSV56922725; API